The global virus filtration market size is expected to reach USD 11.43 billion by 2030, registering a CAGR of 13.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing demand for biological products such as vaccines, therapeutic proteins, blood and blood products, cellular and gene therapy, tissue, and stem cell products is a major factor driving the growth. Biopharmaceuticals are mainly derived from human, animal, and plants and therefore require a scrutinized virus filtration procedure to avoid virus contamination in the production. Therefore, the necessity of this procedure during the production of biologics is expected to boost the market growth.
Many leading biopharmaceuticals and biotechnology manufacturers are involved in R&D to develop innovative biological products. For instance, in 2016, Pfizer Inc. invested USD 7,872.0 million in R&D, which was around 8% more than the R&D investment in 2015. This investment was mainly made to boost innovation and productivity in R&D to accomplish a sustainable pipeline of vaccines and differentiated therapies with lucrative commercial opportunities. Virus filtration is an important step in biologics development, thus, increasing R&D on biologics is expected to drive the product demand.
Request a free sample copy or view report summary: Virus Filtration Market Report
The consumables segment dominated the virus filtration market with the largest revenue share of 53.4% in 2024. The instruments segment is expected to grow at a significant CAGR of 12.9% over the forecast period.
The biologicals segment dominated the virus filtration market with the largest revenue share in 2024. The medical devices segment is expected to grow significantly over the forecast period.
The biopharmaceutical and biotechnology companies led the virus filtration market with the largest revenue share in 2024. The Contract Research Organizations (CRO) sector is expected to grow at the fastest CAGR over the forecast period.
The North America virus filtration market dominated the global market, accounting for the largest revenue share of 42.6% in 2024. The U.S. virus filtration market led the North American market with the largest revenue share in 2024.
The Asia Pacific virus filtration market is expected to grow at the fastest CAGR of 15.0% over the forecast period.
Grand View Research has segmented global virus filtration market report based on product, application, end-use, and region:
Virus Filtration Product Outlook (Revenue, USD Million; 2018 - 2030)
Consumables
Kits and reagents
Others
Instruments
Filtration systems
Chromatography systems
Services
Virus Filtration Application Outlook (Revenue, USD Million; 2018 - 2030)
Biologicals
Vaccines and therapeutics
Blood and blood products
Cellular and gene therapy products
Tissue and tissue products
Stem cell products
Medical devices
Water purification
Air purification
Virus Filtration End-use Outlook (Revenue, USD Million; 2018 - 2030)
Biopharmaceutical & biotechnology companies
Contract research organizations
Medical device companies
Academic institutes & research laboratories
Virus Filtration Regional Outlook (Revenue, USD Million; 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Virus Filtration Market
Merck KGaA
Danaher
Sartorius AG
Thermo Fisher Scientific Inc.
GE HealthCare
Charles River Laboratories
Asahi Kasei Medical Co., Ltd.
WuXi AppTec
Lonza
Clean Biologics
"The quality of research they have done for us has been excellent..."